Drug profile · INN
tobramycin sulfate
TOBRAMYCIN SULFATE
tobramycin sulfate (TOBRAMYCIN SULFATE) is a 70s ribosome inhibitor. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Drug details — tobramycin sulfate
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
tobramycin sulfate (TOBRAMYCIN SULFATE) is a 70s ribosome inhibitor. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
70S ribosome inhibitor
Primary target: 70S ribosome
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is tobramycin sulfate?
tobramycin sulfate (TOBRAMYCIN SULFATE) is a 70s ribosome inhibitor. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for tobramycin sulfate?
TOBRAMYCIN SULFATE is a marketed brand name for tobramycin sulfate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of tobramycin sulfate?
tobramycin sulfate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.